Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Brunner

Showing results (151-160 of 246) with videos related to

Pageof 25
Sort By:
British Journal of Cancer|September 1, 1993
Bioavailability and feasibility of subcutaneous 5-fluorouracilM M Borner, J Kneer, C Crevoisier, et al.
Schweizerische Medizinische Wochenschrift|June 6, 1981
[Results of, and indications for adjuvant chemotherapy in breast cancer]K W Brunner, A Goldhirsch, R Joss, et al.
Advances in Experimental Medicine and Biology|January 1, 1980
Antibodies to total brain gangliosides: titer and specificity of antiseraM M Rapport, L Graf, Y L Huang, et al.
Schweizerische Medizinische Wochenschrift|October 13, 1984
[Adenocarcinoma of the kidney (hypernephroma)]W Probst, R Joss, J Triller, et al.
ACS Applied Materials & Interfaces|February 23, 2013
Are carbon nanotubes a natural solution? Applications in biology and medicineElena Heister, Eric W Brunner, Gregg R Dieckmann, et al.
Cancer Treatment Reports|March 1, 1978
VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedulesF Cavalli, R W Sonntag, F Jungi, et al.
Schweizerische Medizinische Wochenschrift|February 27, 1982
[Stomach cancer. Spontaneous course, therapy and prognosis]R Joss, A Goldhirsch, M Kappeler, et al.
Tumori|March 1, 1977
A combination of cyclophosphamide, methotrexate, vincristine and VP 16-213 (NSC 141 540) in the treatment of bronchogenic carcinomaF Cavalli, E Hasler, H J Ryssel, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|November 1, 1983
[Nausea and vomiting in tumor patients]R Joss, R L Galeazzi, A Goldhirsch, et al.
Schweizerische Medizinische Wochenschrift|February 22, 1975
[Initial results with a epipodophyllotoxin derivative VP 16-213 in the treatment of acute leukemia]F Cavalli, H J Ryssel, K Batz, et al.
Pageof 25

Showing results (151-160 of 246) with videos related to

Sort By:
Pageof 25
British Journal of Cancer|September 1, 1993
Bioavailability and feasibility of subcutaneous 5-fluorouracilM M Borner, J Kneer, C Crevoisier, et al.
Schweizerische Medizinische Wochenschrift|June 6, 1981
[Results of, and indications for adjuvant chemotherapy in breast cancer]K W Brunner, A Goldhirsch, R Joss, et al.
Advances in Experimental Medicine and Biology|January 1, 1980
Antibodies to total brain gangliosides: titer and specificity of antiseraM M Rapport, L Graf, Y L Huang, et al.
Schweizerische Medizinische Wochenschrift|October 13, 1984
[Adenocarcinoma of the kidney (hypernephroma)]W Probst, R Joss, J Triller, et al.
ACS Applied Materials & Interfaces|February 23, 2013
Are carbon nanotubes a natural solution? Applications in biology and medicineElena Heister, Eric W Brunner, Gregg R Dieckmann, et al.
Cancer Treatment Reports|March 1, 1978
VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedulesF Cavalli, R W Sonntag, F Jungi, et al.
Schweizerische Medizinische Wochenschrift|February 27, 1982
[Stomach cancer. Spontaneous course, therapy and prognosis]R Joss, A Goldhirsch, M Kappeler, et al.
Tumori|March 1, 1977
A combination of cyclophosphamide, methotrexate, vincristine and VP 16-213 (NSC 141 540) in the treatment of bronchogenic carcinomaF Cavalli, E Hasler, H J Ryssel, et al.
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|November 1, 1983
[Nausea and vomiting in tumor patients]R Joss, R L Galeazzi, A Goldhirsch, et al.
Schweizerische Medizinische Wochenschrift|February 22, 1975
[Initial results with a epipodophyllotoxin derivative VP 16-213 in the treatment of acute leukemia]F Cavalli, H J Ryssel, K Batz, et al.
Pageof 25